The role of receptor kinase activity and the NPEY960 motif in insulin-accelerated receptor-mediated insulin internalization.

This study used biochemical and quantitative ultrastructural approaches to examine the roles that insulin receptor beta subunit kinase activity, the NPEY motif in the juxtamembrane region, and tyrosine phosphorylation within that domain plays in insulin-accelerated receptor-mediated insulin internalization in CHO cells. Internalization of insulin in cells that expressed kinase-deficient receptors (CHOA1018) or receptors lacking the NPEY Ala954-Asp965 domain (CHO delta 960) was reduced by 80% compared to cells expressing wild-type human insulin receptors (CHOHIRc). Ultrastructural analysis revealed that the decreased internalization in CHOA1018 cells was due to the reduced ability of the kinase deficient receptor to migrate from the microvilli of cultured cells and aggregate on the cell surface. Deletion of the NPEY motif in the juxtamembrane region of the beta subunit severely reduced receptor migration, interfered with the normal aggregation of receptors on the cell surface, and virtually eliminated accumulation of the occupied receptors in the coated invaginations. Replacement of Tyr960 in the NPEY domain/with phenylalanine (CHOF960) had no significant effect on insulin internalization, receptor mobility, aggregation or accumulation in coated invaginations. In contrast, replacement of Tyr960 with alanine (CHOA960) decreased insulin internalization, slowed migration, receptor aggregation and accumulation in coated invaginations. These studies document that kinase activity is required, but not sufficient, for receptor movement from the microvilli and aggregation of occupied receptors on the non-villous surface. An intact NPEY motif or surrounding amino acids, but not the phosphorylation of Tyr960 plays a role in receptor mobility and aggregation and is essential for the accumulation of insulin receptors in coated invaginations.

[1]  J. Blenis,et al.  The Pleckstrin Homology Domain in Insulin Receptor Substrate-1 Sensitizes Insulin Signaling (*) , 1995, The Journal of Biological Chemistry.

[2]  D. McClain,et al.  Insulin Receptor Kinase Activation Releases a Constraint Maintaining the Receptor on Microvilli (*) , 1995, The Journal of Biological Chemistry.

[3]  J. Smith,et al.  Demonstration of specific insulin binding to cytosolic proteins in H35 hepatoma cells, rat liver and skeletal muscle. , 1995, The Biochemical journal.

[4]  Y. Yazaki,et al.  Site-directed mutagenesis of the juxtamembrane domain of the human insulin receptor. , 1993, The Journal of biological chemistry.

[5]  J. Olefsky,et al.  A truncated human insulin receptor missing the COOH-terminal 365 amino acid residues does not undergo insulin-mediated receptor migration or aggregation. , 1993, Endocrinology.

[6]  L. Jarett,et al.  Nonreceptor mediated nuclear accumulation of insulin in H35 rat hepatoma cells , 1992, Journal of cellular physiology.

[7]  K. Siddle,et al.  Internalization of the human insulin receptor. The insulin-independent pathway. , 1992, The Journal of biological chemistry.

[8]  M. White,et al.  Insulin receptors internalize by a rapid, saturable pathway requiring receptor autophosphorylation and an intact juxtamembrane region , 1991, The Journal of cell biology.

[9]  W. Ward,et al.  Multiple pathways for ligand internalization in rat hepatocytes II: Effect of hyperosmolarity and contribution of fluid‐phase endocytosis , 1991, Journal of cellular physiology.

[10]  J. Olefsky,et al.  Tyrosine kinase-defective insulin receptors undergo insulin-induced microaggregation but do not concentrate in coated pits. , 1991, Journal of Biological Chemistry.

[11]  A. Ullrich,et al.  Cytoplasmic juxtamembrane region of the insulin receptor: a critical role in ATP binding, endogenous substrate phosphorylation, and insulin-stimulated bioeffects in CHO cells. , 1991, Biochemistry.

[12]  A. Ullrich,et al.  Receptor-mediated internalization of insulin requires a 12-amino acid sequence in the juxtamembrane region of the insulin receptor beta-subunit. , 1990, The Journal of biological chemistry.

[13]  L. Jarett,et al.  Partial Characterization of Mechanism of Insulin Accumulation in H35 Hepatoma Cell Nuclei , 1990, Diabetes.

[14]  A. Ullrich,et al.  Mutation of the insulin receptor at tyrosine 960 inhibits signal transmission but does not affect its tyrosine kinase activity , 1988, Cell.

[15]  J. Olefsky,et al.  Evidence for Two Independent Pathways of Insulin-Receptor Internalization in Hepatocytes and Hepatoma Cells , 1988, Diabetes.

[16]  L. Jarett,et al.  Preparation and characterization of a colloidal gold-insulin complex with binding and biological activities identical to native insulin. , 1988, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[17]  T. Dull,et al.  A mutant insulin receptor with defective tyrosine kinase displays no biologic activity and does not undergo endocytosis. , 1987, The Journal of biological chemistry.

[18]  T. Gansler,et al.  Heterogeneous effects of inhibitors of receptor processing on insulin binding and intracellular accumulation in various cell types. , 1986, Laboratory investigation; a journal of technical methods and pathology.

[19]  G. Lienhard,et al.  Insulin stimulates fluid-phase endocytosis and exocytosis in 3T3-L1 adipocytes. , 1986, The Journal of biological chemistry.